Clinical Trials in New York

Showing 3021-3040 of 10,830 trials

Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D)

NCT04098068

This study will be looking at whether MK-3475 (pembrolizumab) is effective (anti-tumor activity) and safe in patients with MSI (Microsatellite Unstable) negative cancer with a mutator phenotype.

High Tumor Mutation BurdenHigh TMB (Tumor Mutation Burden)MSS (Microsatellite Stable)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins12 participantsStarted Jan 2018

Baltimore, Maryland, United States • New York, New York, United States • Columbus, Ohio, United States

TERMINATEDPhase 2< 1 mile

Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab

NCT03871829

The purpose of this study is to compare the efficacy (rate of very good partial response \[VGPR\] or better as best response as defined by the International Myeloma Working Group \[IMWG\] criteria) of daratumumab subcutaneous (Dara-SC) in combination with carfilzomib and dexamethasone (Kd) with the efficacy of Kd in participants with relapsed refractory multiple myeloma who were previously exposed to daratumumab to evaluate daratumumab retreatment.

Multiple Myeloma

Janssen Research & Development, LLC88 participantsStarted May 2019

Gilbert, Arizona, United States • Tucson, Arizona, United States • Whittier, California, United States +105 more locations

Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D)

Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab

Find Trials by Condition in New York

Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer

Outcome of Patients with Severe Functional TR According to Medical, Transcatheter or Surgical Treatment

Gastric Emptying in Neonates and Infants After Formula Feeding

Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Using Dexmedetomidine Prior to Intubation in Neonates

Noninvasive Monitoring of Uterine Activity and Fetal Heart Rate

PoNS Clinical Experience Program in Traumatic Brain Injury Patients (TBI)

Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome

A Study of Real-life Current Standards of Care in Patients With Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including Proteasome Inhibitor (PI), Immunomodulatory Drug (IMID), and Cluster of Differentiation 38 (CD38) Monoclonal Antibody Treatment

Oxytocin and Brain Responses in Maternal Addiction

Optimal Post Tpa-Iv Monitoring in Ischemic Stroke

Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure

Strength or Power Training for Patellofemoral Pain

Low Nicotine Content Cigarettes in Vulnerable Populations: Opioid Use Disorder

Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects

Antibiotic Prophylaxis Before Shock Wave Lithotripsy